Capital Advisors Inc’s Bristol-Myers Squibb BMY Stock Holding History

Capital Advisors Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Buy	25,145 +6,866	+38%	+$400K	0.02%	144
2025 Q4	$986K	Buy	18,279 +388	+2%	+$18.7K	0.02%	163
2025 Q3	$807K	Buy	17,891 +5,293	+42%	+$247K	0.01%	164
2025 Q2	$583K	Buy	12,598 +258	+2%	+$12.7K	0.01%	190
2025 Q1	$753K	Sell	12,340 -226	-2%	-$13.2K	0.02%	162
2024 Q4	$711K	Sell	12,566 -137	-1%	-$7.66K	0.01%	164
2024 Q3	$657K	Sell	12,703 -1,213	-9%	-$56.9K	0.01%	175
2024 Q2	$578K	Buy	13,916 +1,156	+9%	+$51.7K	0.01%	179
2024 Q1	$692K	Buy	12,760 +22	+0.2%	+$1.12K	0.01%	173
2023 Q4	$654K	Sell	12,738 -145	-1%	-$7.61K	0.01%	182
2023 Q3	$748K	Sell	12,883 -1,966	-13%	-$120K	0.02%	148
2023 Q2	$950K	Buy	14,849 +836	+6%	+$56.1K	0.02%	138
2023 Q1	$971K	Sell	14,013 -414	-3%	-$29.2K	0.03%	135
2022 Q4	$1.04M	Sell	14,427 -844	-6%	-$63.6K	0.03%	131
2022 Q3	$1.08M	Buy	15,271 +1,485	+11%	+$108K	0.03%	125
2022 Q2	$1.06M	Sell	13,786 -114	-0.8%	-$8.68K	0.03%	125
2022 Q1	$1.01M	Sell	13,900 -1,214	-8%	-$81.5K	0.03%	124
2021 Q4	$942K	Sell	15,114 -295,657	-95%	-$17.3M	0.03%	128
2021 Q3	$18.4M	Buy	310,771 +3,281	+1%	+$216K	0.55%	72
2021 Q2	$20.5M	Buy	307,490 +24,634	+9%	+$1.61M	0.62%	68
2021 Q1	$17.9M	Buy	282,856 +20,526	+8%	+$1.28M	0.58%	73
2020 Q4	$16.3M	Buy	262,330 +33,721	+15%	+$2.07M	0.58%	70
2020 Q3	$13.8M	Buy	228,609 +11,312	+5%	+$681K	0.56%	66
2020 Q2	$13.3M	Buy	217,297 +196,686	+954%	+$11.8M	0.55%	64
2020 Q1	$1.15M	Sell	20,611 -905	-4%	-$55.3K	0.06%	92
2019 Q4	$1.38M	Buy	21,516 +1,266	+6%	+$72.5K	0.06%	109
2019 Q3	$918K	Hold	20,250	–	–	0.05%	118
2019 Q2	$918K	Buy	20,250 +10,793	+114%	+$503K	0.05%	118
2019 Q1	$451K	Sell	9,457 -12,453	-57%	-$620K	0.05%	106
2018 Q4	$1.14M	Buy	21,910 +738	+3%	+$39.7K	0.07%	110
2018 Q3	$1.31M	Sell	21,172 -66	-0.3%	-$3.92K	0.08%	112
2018 Q2	$1.18M	Sell	21,238 -140,838	-87%	-$7.61M	0.07%	119
2018 Q1	$10.3M	Buy	162,076 +6,466	+4%	+$416K	0.62%	52
2017 Q4	$9.54M	Sell	155,610 -1,180	-0.8%	-$73.8K	0.56%	62
2017 Q3	$9.99M	Sell	156,790 -4,079	-3%	-$238K	0.61%	61
2017 Q2	$8.96M	Sell	160,869 -53	-0%	-$2.88K	0.56%	61
2017 Q1	$8.75M	Buy	160,922 +6,659	+4%	+$365K	0.57%	62
2016 Q4	$9.02M	Buy	154,263 +11,905	+8%	+$651K	0.63%	53
2016 Q3	$7.68M	Buy	142,358 +30,693	+27%	+$1.97M	1.15%	45
2016 Q2	$8.21M	Buy	111,665 +2,461	+2%	+$174K	1.27%	38
2016 Q1	$6.98M	Buy	109,204 +1,013	+0.9%	+$63.9K	1.14%	43
2015 Q4	$7.44M	Buy	108,191 +2,971	+3%	+$196K	1.3%	34
2015 Q3	$6.23M	Buy	105,220 +3,856	+4%	+$245K	1.12%	45
2015 Q2	$6.74M	Sell	101,364 -5,314	-5%	-$350K	1.16%	46
2015 Q1	$6.88M	Buy	106,678 +96,150	+913%	+$6.02M	0.85%	51
2014 Q4	$621K	Buy	10,528 +747	+8%	+$42.1K	0.12%	80
2014 Q3	$501K	Hold	9,781	–	–	0.1%	81
2014 Q2	$474K	Hold	9,781	–	–	0.09%	84
2014 Q1	$508K	Hold	9,781	–	–	0.11%	81
2013 Q4	$520K	Buy	9,781 +334	+4%	+$17K	0.11%	79
2013 Q3	$437K	Sell	9,447 -412	-4%	-$18.1K	0.1%	78
2013 Q2	$441K	Buy	+9,859	New	+$428K	0.12%	75

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Advisors Inc's BMY Position: Q1 2026 in Review

Capital Advisors Inc increased its Bristol-Myers Squibb (BMY) stake by 38% in Q1 2026, buying an estimated $400K and bringing the position to 25,145 shares worth $1.53M. The position accounts for 0.02% of the portfolio, ranked #144.

Capital Advisors Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.5M in Q2 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capital Advisors Inc held 25,145 shares of Bristol-Myers Squibb worth $1.53M as of Q1 2026.
Capital Advisors Inc bought 6,866 Bristol-Myers Squibb shares in Q1 2026, an estimated $400K.
Bristol-Myers Squibb made up 0.02% of Capital Advisors Inc's portfolio in Q1 2026, its #144 holding.
Capital Advisors Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Capital Advisors Inc's Bristol-Myers Squibb position peaked at $20.5M in Q2 2021.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capital Advisors Inc's 13F filing for Q1 2026, filed 27 Apr 2026.